Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition. / Foged, Camilla; Arigita, Carmen; Sundblad, Anne; Jiskoot, Wim; Storm, Gert; Frøkjær, Sven.
In: Vaccine, Vol. 22, No. 15-16, 2004, p. 1903-13.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition
AU - Foged, Camilla
AU - Arigita, Carmen
AU - Sundblad, Anne
AU - Jiskoot, Wim
AU - Storm, Gert
AU - Frøkjær, Sven
N1 - Keywords: Animals; Antigens; Cells, Cultured; Dendritic Cells; Drug Carriers; Flow Cytometry; Fluorescent Antibody Technique; Humans; Lipid Bilayers; Liposomes; Mannose; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Monocytes; Particle Size; Subcellular Fractions
PY - 2004
Y1 - 2004
N2 - Vaccine efficacy might be improved by exploiting the potent antigen presenting properties of dendrite cells (DCs), since their ability to stimulate specific major histocompatibility complex-restricted immune responses has been well documented during the recent years. In that light, we investigated how the interaction of antigen-containing liposomes with DCs was affected by the bilayer composition. Monocyte-derived human DCs and murine bone marrow-derived DCs were analysed and compared upon in vitro incubation with liposomes by flow cytometry and confocal microscopy. Anionic liposomes with a bilayer composition of phosphatidylcholine, cholesterol and phosphatidylglycerol or phosphatidylserine interacted with a limited fraction of the total DC population in case of both DC types. Inclusion of mannosylated phosphatidylethanolamine (Man-PE) for targeting to the mannose receptor (MR) increased the interaction of negatively charged liposomes with both human and murine DCs. This increase could be blocked in human DCs by addition of the polysaccharide mannan indicating that uptake might be mediated by the mannose receptor. Cationic liposomes containing trimethyl ammonium propane interacted with a very high percentage of both DC types and could be detected in high amounts intracellularly. In conclusion, liposome bilayer composition has an important effect on interaction with DCs and might be critical for the vaccination outcome.
AB - Vaccine efficacy might be improved by exploiting the potent antigen presenting properties of dendrite cells (DCs), since their ability to stimulate specific major histocompatibility complex-restricted immune responses has been well documented during the recent years. In that light, we investigated how the interaction of antigen-containing liposomes with DCs was affected by the bilayer composition. Monocyte-derived human DCs and murine bone marrow-derived DCs were analysed and compared upon in vitro incubation with liposomes by flow cytometry and confocal microscopy. Anionic liposomes with a bilayer composition of phosphatidylcholine, cholesterol and phosphatidylglycerol or phosphatidylserine interacted with a limited fraction of the total DC population in case of both DC types. Inclusion of mannosylated phosphatidylethanolamine (Man-PE) for targeting to the mannose receptor (MR) increased the interaction of negatively charged liposomes with both human and murine DCs. This increase could be blocked in human DCs by addition of the polysaccharide mannan indicating that uptake might be mediated by the mannose receptor. Cationic liposomes containing trimethyl ammonium propane interacted with a very high percentage of both DC types and could be detected in high amounts intracellularly. In conclusion, liposome bilayer composition has an important effect on interaction with DCs and might be critical for the vaccination outcome.
U2 - 10.1016/j.vaccine.2003.11.008
DO - 10.1016/j.vaccine.2003.11.008
M3 - Journal article
C2 - 15121302
VL - 22
SP - 1903
EP - 1913
JO - Vaccine
JF - Vaccine
SN - 0264-410X
IS - 15-16
ER -
ID: 9041088